Sofwave Medical Ltd
TASE:SOFW
Net Margin
Sofwave Medical Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
IL |
S
|
Sofwave Medical Ltd
TASE:SOFW
|
692.7m ILS |
-7%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
230.3B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
182.6B USD |
28%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
149.8B USD |
12%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
143.5B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
110.7B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
51.8B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
48.3B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
43.5B USD |
75%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42.3B USD |
23%
|
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
275.5B CNY |
31%
|
Sofwave Medical Ltd
Glance View
Sofwave Medical Ltd. engages in development, production, marketing, maintenance, and distribution of medical technology for firming and rejuvenating facial and neck skin. The firm operates itself and through its subsidiaries in the field of development, production, marketing, support and distribution of medical technology Sofwave that delivers Synchronous Ultrasound Parallel Beam SUPERB technology for skin tightening and rejuvenation treatments for the face and neck, which provides a non-invasive solution for skin rejuvenation and tightening, in a safe and clinically effective manner. In addition, the group provides services technical and clinical support for the product it provides. The firm has subsidiary in United States -Sofwave Medical Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Sofwave Medical Ltd's most recent financial statements, the company has Net Margin of -7.4%.